Analyst Ratings for Cytokinetics (CYTK)
CYTK Rating Summary
CYTK Price Target Summary
- Highest: $146.00 (B.Riley)
- Lowest: $69.00 (UBS)
- Average: $100.79
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$100.79 (+42.5%)
* Over Last 12-Mos
Rating Score: 8.8 / 10
Percentile Rank: 88%
Avg. $ Target:
$100.79 (+42.5%)
* Over Last 12-Mos
Rating Score: 8.8 / 10
Percentile Rank: 88%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/18/2026 | Citi | Eric Joseph | New Coverage | Buy (N/A) |
99.00 (N/A) |
75.85 (70.71) |
-6.78% | Details |
| 4/10/2026 | Wells Fargo » Updated 5/7/2026 |
Yanan Zhu | New Coverage | Overweight (N/A) |
105.00 (95.00) |
64.59 (70.71) |
9.48% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
